Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 26 for:    mRNA-1273
Previous Study | Return to List | Next Study

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04860297
Recruitment Status : Recruiting
First Posted : April 26, 2021
Last Update Posted : April 29, 2021
Sponsor:
Information provided by (Responsible Party):
ModernaTX, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 26, 2021
Estimated Study Completion Date : August 26, 2022